CATHERINE REYNOLDS: Open Payments
NPI 1942599147 · WHITE HOUSE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$733 in 42 payments from 15 companies in 2025. Trend: 2023 $780 · 2024 $1,014 · 2025 $733
Food & beverage: $733
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $153 |
| GlaxoSmithKline, LLC. | 5 | $89 |
| Lilly USA, LLC | 4 | $71 |
| Otsuka America Pharmaceutical, Inc. | 3 | $62 |
| SANOFI-AVENTIS U.S. LLC | 4 | $59 |
| Sumitomo Pharma America, Inc. | 2 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| Phathom Pharmaceuticals, Inc. | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Lundbeck LLC | 2 | $30 |
Products named: Wegovy, REXULTI, TRELEGY ELLIPTA, TZIELD, Ozempic, MOUNJARO, GEMTESA, CAPLYTA.
Industry payments across TN — which companies pay providers there.
